Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Spear Dermatology Products, Inc.
INSERTING and REPLACING Spear Dermatology Products, Inc. Introduces Refissa TM Tretinoin Cream USP Emollient 0.05%
June 22nd, 2009
Insert after sixth graph of release: Important Safety Information: Refissa 0.05% is a prescription medicine that may reduce fine facial wrinkles and mottled hyperpigmentation in patients who also protect their skin from the sun and wear sunscreen daily. Refissa does not eliminate wrinkles, repair sun damaged skin or reverse photo-aging. Avoid medicines that may increase your sensitivity to sunlight, ask your pharmacist. Do not use if you are pregnant, attempting pregnancy, or nursing. Refissa, early in treatment, may cause redness, itching, burning, stinging and peeling. Please see Full Prescribing Information at www.refissa.com. The corrected release reads: SPEAR DERMATOLOGY PRODUCTS,...
Source: Biotech Business Week (2009-06-22)
|
